Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China
· Delayed Price · Currency is CNY 13.95
+0.02 (0.14%)
Apr 29, 2026, 3:00 PM CST
SHA:600557 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,898 | 7,989 | 7,756 | 11,999 | 10,961 | 7,055 | Upgrade
|
| Market Cap Growth | -1.71% | 3.00% | -35.36% | 9.47% | 55.36% | 17.01% | Upgrade
|
| Enterprise Value | 5,945 | 6,033 | 5,802 | 9,984 | 9,682 | 6,533 | Upgrade
|
| Last Close Price | 13.95 | 14.11 | 13.62 | 20.09 | 18.13 | 11.84 | Upgrade
|
| PE Ratio | 25.83 | 26.28 | 19.79 | 25.85 | 25.23 | 22.01 | Upgrade
|
| Forward PE | 22.50 | 14.69 | 12.25 | 19.80 | 22.32 | 16.11 | Upgrade
|
| PS Ratio | 2.40 | 2.43 | 1.99 | 2.47 | 2.52 | 1.93 | Upgrade
|
| PB Ratio | 1.58 | 1.59 | 1.65 | 2.39 | 2.22 | 1.58 | Upgrade
|
| P/TBV Ratio | 1.75 | 1.77 | 1.81 | 2.56 | 2.46 | 1.78 | Upgrade
|
| P/FCF Ratio | 88.93 | 89.95 | 34.35 | 18.15 | 13.97 | 9.58 | Upgrade
|
| P/OCF Ratio | 12.93 | 13.08 | 11.04 | 12.34 | 11.01 | 7.77 | Upgrade
|
| PEG Ratio | - | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 | Upgrade
|
| EV/Sales Ratio | 1.81 | 1.83 | 1.49 | 2.05 | 2.23 | 1.79 | Upgrade
|
| EV/EBITDA Ratio | 10.42 | 10.66 | 11.93 | 16.52 | 16.44 | 12.88 | Upgrade
|
| EV/EBIT Ratio | 15.85 | 16.09 | 20.01 | 24.37 | 24.27 | 20.41 | Upgrade
|
| EV/FCF Ratio | 66.93 | 67.92 | 25.69 | 15.10 | 12.34 | 8.87 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.47 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.32 | Upgrade
|
| Net Debt / Equity Ratio | -0.43 | -0.43 | -0.47 | -0.49 | -0.36 | -0.20 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.79 | -3.79 | -4.59 | -4.03 | -3.00 | -1.73 | Upgrade
|
| Net Debt / FCF Ratio | -24.17 | -24.17 | -9.89 | -3.69 | -2.25 | -1.19 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.55 | 0.70 | 0.68 | 0.60 | Upgrade
|
| Inventory Turnover | 1.89 | 1.89 | 2.39 | 3.62 | 3.57 | 2.87 | Upgrade
|
| Quick Ratio | 1.60 | 1.60 | 1.44 | 1.73 | 1.83 | 1.70 | Upgrade
|
| Current Ratio | 1.93 | 1.93 | 1.76 | 2.00 | 2.09 | 1.98 | Upgrade
|
| Return on Equity (ROE) | 6.33% | 6.33% | 7.83% | 8.92% | 9.40% | 7.37% | Upgrade
|
| Return on Assets (ROA) | 3.40% | 3.40% | 2.57% | 3.66% | 3.89% | 3.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.49% | 12.11% | 11.36% | 14.13% | 11.70% | 8.28% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.30% | 7.30% | 6.00% | 8.00% | 8.00% | 7.00% | Upgrade
|
| Earnings Yield | 3.85% | 3.81% | 5.05% | 3.87% | 3.96% | 4.54% | Upgrade
|
| FCF Yield | 1.12% | 1.11% | 2.91% | 5.51% | 7.16% | 10.44% | Upgrade
|
| Dividend Yield | - | - | - | 1.85% | 1.21% | - | Upgrade
|
| Payout Ratio | 30.24% | 30.24% | 54.50% | 27.69% | 0.57% | 3.45% | Upgrade
|
| Buyback Yield / Dilution | 2.33% | 2.33% | 0.68% | -0.16% | -1.20% | 4.21% | Upgrade
|
| Total Shareholder Return | 2.33% | 2.33% | 0.68% | 1.70% | 0.01% | 4.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.